RAFAEL HOLDINGS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
RAFAEL HOLDINGS, INC. (RFL) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $4.90 per share for the 12-month period ending 2021-07-31, per its 10-K filed 2022-10-31.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2022-10-31
- RAFAEL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2020-10-31 was $4.90.
- RAFAEL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2018-10-31 was $4.90.
- RAFAEL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $4.90, a 0.00% change from fiscal 2020.
- RAFAEL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2020 was $4.90, a 0.00% change from fiscal 2019.
- RAFAEL HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2019 was $4.90.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2021-07-31 | $4.90 10-K · filed 2022-10-31 | |||
| 2021-01-31 | $4.90 10-Q · filed 2021-03-17 | |||
| 2020-10-31 | $4.90 10-Q · filed 2020-12-15 | |||
| 2020-07-31 | $4.90 10-K · filed 2021-10-18 | |||
| 2020-04-30 | $4.90 10-Q · filed 2020-06-09 | |||
| 2019-07-31 | $4.90 10-K · filed 2020-10-29 | |||
| 2019-01-31 | $4.90 10-Q · filed 2019-03-12 | |||
| 2018-10-31 | $4.90 10-Q · filed 2018-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |